← back to search

Freddy E. Escorcia

National Institutes of Health · US
Area of research
Radiology, Nuclear Medicine and Imaging · Oncology
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, and Peptidase Inhibition and Analysis.
h-index
24
citations
2,528
works
170
NIH funding
primary concept
email

Recent publications

Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model
Molecular Cancer Therapeutics 2023cited by 10position: middledoi
H<sub>2</sub>BZmacropa-NCS: A Bifunctional Chelator for Actinium-225 Targeted Alpha Therapy
Bioconjugate Chemistry 2022cited by 55position: middledoi
<sup>225</sup>Ac-MACROPATATE: A Novel α-Particle Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors
Journal of Nuclear Medicine 2022cited by 40position: lastdoi
ASTRO's Framework for Radiopharmaceutical Therapy Curriculum Development for Trainees
International Journal of Radiation Oncology*Biology*Physics 2022cited by 15position: lastdoi
Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand
Chemical Science 2021cited by 90position: middledoi
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.
PubMed 2021cited by 52position: middledoi
iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy
Cancer Research 2020cited by 57position: middledoi
Nontranscriptional Role of Hif-1α in Activation of γ-Secretase and Notch Signaling in Breast Cancer
Cell Reports 2014cited by 125position: middledoi
Self-assembly of carbon nanotubes and antibodies on tumours for targeted amplified delivery
Nature Nanotechnology 2013cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kwamena E. Baidoo · National Institutes of Health4 papers (2021–2023)Justin J. Wilson · University of California, Santa Barbara3 papers (2021–2022)Nicholas T. Gutsche · Center for Cancer Research2 papers (2021–2022)Stanley Fayn · University of Illinois Urbana-Champaign2 papers (2022–2022)David A. Scheinberg · Memorial Sloan Kettering Cancer Center2 papers (2013–2014)Nikki A. Thiele · Oak Ridge National Laboratory2 papers (2021–2022)Anna King · National Cancer Institute2 papers (2022–2022)Samira M. Sadowski · Center for Cancer Research2 papers (2022–2023)Carlos H. Villa · Universidad Nacional José María Arguedas2 papers (2013–2014) · 1 papers (2022–2022)Danica Chiu · Cornell University1 papers (2014–2014)Peter L. Choyke · University Research Co (United States)1 papers (2022–2022)Ruby F. Meredith · University of Alabama at Birmingham1 papers (2022–2022) · 1 papers (2021–2021)Luís Felipe Campesato · Parker Institute for Cancer Immunotherapy1 papers (2020–2020)Susan J. Knox · Palo Alto University1 papers (2022–2022)Hanwen Zhang · City University of Hong Kong, Shenzhen Research Institute1 papers (2021–2021)Robert F. Hobbs · Oak Ridge National Laboratory1 papers (2022–2022)J. Justin Mulvey · Memorial Sloan Kettering Cancer Center1 papers (2013–2013)Emily Casey · Twitter (United States)1 papers (2013–2013)